BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20219002)

  • 1. Risk Malignancy Index (RMI) in patients with abnormal pelvic mass: Comparing RMI 1, 2 and 3 in an Australian population.
    Kader Ali Mohan GR; Jaaback K; Proietto A; Robertson R; Angstetra D
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):77-80. PubMed ID: 20219002
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
    Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
    Ong C; Biswas A; Choolani M; Low JJ
    Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk of malignancy index in preoperative diagnosis of ovarian cancer.
    Ma S; Shen K; Lang J
    Chin Med J (Engl); 2003 Mar; 116(3):396-9. PubMed ID: 12781045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting.
    Manegold-Brauer G; Buechel J; Knipprath-Mészaros A; Schoetzau A; Hacker NF; Tercanli S; Lapaire O; Heinzelmann-Schwarz V
    Int J Gynecol Cancer; 2016 Jul; 26(6):1062-9. PubMed ID: 27177281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gynecologic approach to evaluation of pelvic masses in women.
    Brown G
    JAAPA; 2012 Aug; 25(8):46-50. PubMed ID: 22928277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer].
    Ma S; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):162-4. PubMed ID: 11783394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
    Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.
    Morgante G; la Marca A; Ditto A; De Leo V
    Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual abdominal cystic mass.
    Montaruli E; Branchereau S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):641; answer 642. PubMed ID: 23018573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive values of the ultrasound parameters, CA-125 and risk of malignancy index in patients with ovarian cancer.
    Antovska SV; Bashevska N; Aleksioska N
    Klin Onkol; 2011; 24(6):435-42. PubMed ID: 22257232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer.
    Yazbek J; Aslam N; Tailor A; Hillaby K; Raju KS; Jurkovic D
    Ultrasound Obstet Gynecol; 2006 Sep; 28(3):320-4. PubMed ID: 16881074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?
    Bailey J; Tailor A; Naik R; Lopes A; Godfrey K; Hatem HM; Monaghan J
    Int J Gynecol Cancer; 2006; 16 Suppl 1():30-4. PubMed ID: 16515564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of screening for ovarian cancer using symptoms as selection criteria.
    Rufford BD; Jacobs IJ; Menon U
    BJOG; 2007 Jan; 114(1):59-64. PubMed ID: 17233861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three risk of malignancy indices in evaluation of pelvic masses.
    Manjunath AP; Pratapkumar ; Sujatha K; Vani R
    Gynecol Oncol; 2001 May; 81(2):225-9. PubMed ID: 11330953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.
    Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T
    Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triage of ovarian masses.
    Chia YN; Marsden DE; Robertson G; Hacker NF
    Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):322-8. PubMed ID: 18532966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative evaluation of ovarian mass: risk of malignancy index.
    Asif N; Sattar A; Dawood MM; Rafi T; Aamir M; Anwar M
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):128-31. PubMed ID: 15228841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol.
    Van Calster B; Timmerman D; Valentin L; McIndoe A; Ghaem-Maghami S; Testa AC; Vergote I; Bourne T
    BJOG; 2012 May; 119(6):662-71. PubMed ID: 22390753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and menopausal status].
    Hagen B; Tingulstad S; Onsrud M; Moen M; Kiserud T; Eik-Nes S; Halvorsen T; Nustad K
    Tidsskr Nor Laegeforen; 1995 Mar; 115(7):820-2. PubMed ID: 7701488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.